Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

World journal of gastroenterology - 21 Sept 2013

Abu-Wasel Bassam, Walsh Caolan, Keough Valerie, Molinari Michele

Abstract excerpt

Polycystic liver diseases (PLD) represent a group of genetic disorders in which cysts occur in the liver (autosomal dominant polycystic liver disease) or in combination with cysts in the kidneys (autosomal dominant polycystic kidney disease). Regardless of the genetic mutations, the natural history of these disorders is alike. The natural history of PLD is characterized by a continuous increase in the volume and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cysts
Share to Diagnostic Imaging
Share to Incidence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Diseases

Share to Predictive Value of Tests

Share to Prevalence

Share to Severity of Illness Index

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 24124322
DOI: 10.3748/wjg.v19.i35.5775
PMCID: PMC3793132

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.PMID 24124322Read ↗

Polycystic liver diseases: advanced insights into the molecular mechanisms.Semantic proximity Read ↗

New Advances in Polycystic Liver Diseases.Semantic proximity Read ↗

Management of polycystic liver disease.Semantic proximity Read ↗

Polycystic disease of the liverSemantic proximity Read ↗

Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.Semantic proximity Read ↗

Polycystic disease of the liverSemantic proximity Read ↗

Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases.Semantic proximity Read ↗

Polycystic liver disease: a clinical review.Semantic proximity Read ↗

Advances in management of polycystic liver disease.Semantic proximity Read ↗

Cholangiociliopathies: genetics, molecular mechanisms and potential therapiesSemantic proximity Read ↗

Adult Congenital Hepatic Fibrosis and Autosomal Dominant Polycystic Kidney Disease with PAX2 and PKD1 Variants: A Case ReportSemantic proximity Read ↗

Autosomal Dominant Polycystic Kidney Disease: Extrarenal InvolvementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.